Am Heart J

1. DILLINGER JG, Pezel T, Batias L, Angoulvant D, et al
   Twice-a-day administration of aspirin in patients with diabetes mellitus or aspirin resistance after acute coronary syndrome: Rationale and design of the randomized ANDAMAN trial.
   Am Heart J. 2025 Apr 21:S0002-8703(25)00132-2. doi: 10.1016/j.ahj.2025.
   

   >> Share

   
   

   
   Ann Intern Med

2. MAKAM AN, Bailey L, Anderson N, Bellitti K, et al
   Availability of Cardioprotective Medications for Type 2 Diabetes in the Medicaid Program.
   Ann Intern Med. 2025 Apr 22. doi: 10.7326/ANNALS-24-01449.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

3. MARATHE CK, Thorat VG, Kokate IP, Pawar AT, et al
   Antidepressant- and anxiolytic-like effects of linezolid in streptozotocin-induced diabetic mice via modulation of brain serotonin and plasma corticosterone activity.
   Biochem Biophys Res Commun. 2025;765:151843.
   

   >> Share

   
   

   
   BMC Ophthalmol

4. THOMPSON K, Alshaikhsalama A, L Wang A
   Racial disparities in patients with proliferative diabetic retinopathy treated with pars plana vitrectomy in an underserved population.
   BMC Ophthalmol. 2025;25:232.
   

   >> Share

   
   

   
   Br J Ophthalmol

5. PARIS A, Volpe G, Perruchoud-Ader K, Casanova A, et al
   Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study.
   Br J Ophthalmol. 2024 Nov 12:bjo-2024-326053. doi: 10.1136/bjo-2024-326053.
   

   >> Share

   
   

   
   Diabet Med

6. LUND E, Vistisen D, Svensson J, Birkebaek NH, et al
   Age- and sex-dependent lipid trajectories in children and adolescents with type 1 diabetes-A Danish nationwide registry-based study.
   Diabet Med. 2025 Apr 22:e70055. doi: 10.1111/dme.70055.
   

   >> Share

   
   
7. HOLMES-TRUSCOTT E, Jordan J, Churilov L, Davis W, et al
   Accelerating diabetes innovation for real-world community impact through interdisciplinary research: Who is at the table?
   Diabet Med. 2025 Apr 19:e70057. doi: 10.1111/dme.70057.
   

   >> Share

   
   

   
   Diabetes

8. FLATT AJ, Matus AM, Gallop RJ, Markmann E, et al
   beta-Cell Secretory Capacity Predicts Metabolic Outcomes Over 6 Years After Human Islet Transplantation.
   Diabetes. 2025;74:749-759.
   

   >> Share

   
   
9. YANG S, Xiong L, Liao T, Li L, et al
   Deubiquitinating Enzyme USP2 Alleviates Muscle Atrophy by Stabilizing PPAR-gamma.
   Diabetes. 2025;74:773-786.
   

   >> Share

   
   
10. YOUSUF MS, Mancilla Moreno M, Woodall BJ, Thakur V, et al
    Diroximel Fumarate Acts Through Nrf2 to Attenuate Methylglyoxal-Induced Nociception in Mice and Decrease ISR Activation in DRG Neurons.
    Diabetes. 2025;74:827-837.
    

    >> Share

    
    
11. XIE QY, Granato A, Wong A, Yau C, et al
    Metabolic dysfunction associated with alterations in gut microbiota in adolescents with obesity.
    Diabetes. 2025 Feb 21:db240866. doi: 10.2337/db24-0866.
    

    >> Share

    
    
12. PAGE B
    Diabetes Spotlight: Kirk Habegger, PhD: The Impact of Glucagon on Metabolic Processes.
    Diabetes. 2025;74:665.
    

    >> Share

    
    
13. D'ALESSIO D, Kahn SE
    The Normal 93: Linking the beta-Cell and Insulin Sensitivity: Revisiting a 1993 Diabetes Classic by Kahn et al.
    Diabetes. 2025;74:668-671.
    

    >> Share

    
    
14. CHAN JSF, Ussher JR
    Of Mice and Men: Toward a Better Model of Diabetic Cardiomyopathy With Application in Female Animals.
    Diabetes. 2025;74:689-690.
    

    >> Share

    
    
15. ROMAN J, Yuan Y, Xu Y, Zhu Q, et al
    A functional and mechanistic explanation for the unique clinical success of the glucokinase activator dorzagliatin for treatment of type 2 diabetes.
    Diabetes. 2025 Apr 24:db250066. doi: 10.2337/db25-0066.
    

    >> Share

    
    
16. SCALA R, Li Y, Gao J, York NW, et al
    Paradoxical maturity-onset diabetes of the young (MODY) arising from loss-of-function mutations in ATP-sensitive potassium channels.
    Diabetes. 2025 Apr 24:db250110. doi: 10.2337/db25-0110.
    

    >> Share

    
    
17. LI D, Zhang J, Han X, Kong L, et al
    Targeting tsRNA-1797 alleviates diabetes-induced vascular dysfunction through modulating purine metabolism.
    Diabetes. 2025 Apr 24:db241158. doi: 10.2337/db24-1158.
    

    >> Share

    
    
18. CEFALU WT, Cerio RJ, Silva CM, Wallace JA, et al
    NIDDK: Celebrating 75 Years of Advancing Diabetes Research.
    Diabetes. 2025 Apr 24:dbi250023. doi: 10.2337/dbi25-0023.
    

    >> Share

    
    
19. HERING BJ, Rickels MR, Bellin MD, Millman JR, et al
    Advances in Cell Replacement Therapies for Diabetes.
    Diabetes. 2025 Apr 24:db250037. doi: 10.2337/db25-0037.
    

    >> Share

    
    
20. PARENT AV, Agarwal A, Alvarez-Dominguez JR, Arrojo E Drigo R, et al
    Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human Islet Research Network (HIRN) Initiative.
    Diabetes. 2025 Apr 24:db250097. doi: 10.2337/db25-0097.
    

    >> Share

    
    
21. JONES TLZ, Kusmartseva I, Litovsky S, Thakar R, et al
    The Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D): An NIDDK Initiative to Advance Understanding of Mechanisms Underlying Cardiovascular Disease in Type 1 Versus Type 2 Diabetes.
    Diabetes. 2025 Apr 24:db250017. doi: 10.2337/db25-0017.
    

    >> Share

    
    
22. COSTANZO MC, Akolkar B, Claussnitzer M, Florez JC, et al
    Accelerating Medicines Partnership in Type 2 Diabetes and Common Metabolic Diseases: Collaborating to Maximize the Value of Genetic and Genomic Data.
    Diabetes. 2025 Apr 24:db250042. doi: 10.2337/db25-0042.
    

    >> Share

    
    
23. SILVA CM, Thornton PL, Artis Dickerson S, Eggerman TL, et al
    Celebrating the Past, Present, and Future of NIDDK-Supported Research Centers Focused on Diabetes, Endocrinology, and Metabolic Diseases.
    Diabetes. 2025 Apr 24:db250039. doi: 10.2337/db25-0039.
    

    >> Share

    
    
24. LI H, Xu L, Venkata SPM, Minjares M, et al
    G protein-coupled receptor 35 suppresses oxidative stress response 1 in diabetic wound healing.
    Diabetes. 2025 Apr 23:db240737. doi: 10.2337/db24-0737.
    

    >> Share

    
    

    
    Diabetes Care

25. BOWEN ME, Lingvay I, Meneghini L, Moran B, et al
    Derivation and Validation of D-RISK: An Electronic Health Record-Driven Risk Score to Detect Undiagnosed Dysglycemia in Clinical Practice.
    Diabetes Care. 2025;48:703-710.
    

    >> Share

    
    
26. ZHAO H, Zhang B, Zhuo L, Yin Y, et al
    Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors and Epilepsy: A Population-Based Study Using Target Trial Emulation.
    Diabetes Care. 2025;48:827-836.
    

    >> Share

    
    
27. SMEDEGAARD S, Kampmann U, Ovesen PG, Suder LB, et al
    Premeal Whey Protein Lowers Postprandial Blood Glucose in Women With Gestational Diabetes Mellitus: A Randomized, Crossover Clinical Trial.
    Diabetes Care. 2025 Apr 22:dc242831. doi: 10.2337/dc24-2831.
    

    >> Share

    
    
28. WEN X, Miao G, Fretts AM, Chen M, et al
    Lipidomic Markers of Processed Meat and Unprocessed Red Meat Intake and Risk of Diabetes in American Indians.
    Diabetes Care. 2025 Apr 23:dc242828. doi: 10.2337/dc24-2828.
    

    >> Share

    
    
29. LUCKETT AM, Oram RA, Deutsch AJ, Ortega HI, et al
    Standardized Measurement of Type 1 Diabetes Polygenic Risk Across Multiancestry Population Cohorts.
    Diabetes Care. 2025 Apr 23:dc250142. doi: 10.2337/dc25-0142.
    

    >> Share

    
    
30. ECHOUFFO-TCHEUGUI JB, Chakkalakal RJ, Ali MK
    Is the Current Lifestyle Modification Approach to Diabetes Prevention in the U.S. a Success?
    Diabetes Care. 2025 Apr 23:dci240040. doi: 10.2337/dci24-0040.
    

    >> Share

    
    
31. WEXLER DJ, Garvey WT, Ghosh A, Kazemi EJ, et al
    Weight Gain Was Associated With Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled Trial.
    Diabetes Care. 2025 Apr 23:dc242825. doi: 10.2337/dc24-2825.
    

    >> Share

    
    
32. BAPAT P, Dhaliwal S, Song C, Zhang Y, et al
    Capillary Ketone Level and Future Ketoacidosis Risk in Patients With Type 1 Diabetes Using Sodium-Glucose Cotransporter Inhibitors.
    Diabetes Care. 2025 Apr 23:dc250125. doi: 10.2337/dc25-0125.
    

    >> Share

    
    
33. LI Z, Ali MK, Varghese JS
    Leveraging Historical Patient Data to Identify Undiagnosed Diabetes and Prediabetes in Routine Care.
    Diabetes Care. 2025;48:682-684.
    

    >> Share

    
    
34. LINDE S, Egede LE
    Historic Residential Redlining and Diabetes: Mediating Pathways and Policy Solutions.
    Diabetes Care. 2025;48:685-687.
    

    >> Share

    
    
35. BOONPATTHARATTHITI K, Wechkunanukul K, Mayang N, Lee EL, et al
    Comparison of Insulin Titration Strategies for Glycemic Control in Type 2 Diabetes: A Systematic Review and Network Meta-analysis.
    Diabetes Care. 2025;48:837-845.
    

    >> Share

    
    
36. CHRISTIAENS A, Boureau AS, Hadjadj S, Cariou B, et al
    Response to Comment on Christiaens et al. Diabetes Overtreatment and Hypoglycemia in Older Patients With Type 2 Diabetes on Insulin Therapy: Insights From the HYPOAGE Cohort Study. Diabetes Care 2025;48:61-66.
    Diabetes Care. 2025;48:e79-e80.
    

    >> Share

    
    
37. CHENG CY, Huang CN, Yang YS, Kornelius E, et al
    Comment on Christiaens et al. Diabetes Overtreatment and Hypoglycemia in Older Patients With Type 2 Diabetes on Insulin Therapy: Insights From the HYPOAGE Cohort Study. Diabetes Care 2025;48:61-66.
    Diabetes Care. 2025;48:e77-e78.
    

    >> Share

    
    
38. JACOBSEN LM, Felton JL, Nathan BM, Speake C, et al
    Type 1 Diabetes TrialNet: Leading the Charge in Disease Prediction, Prevention, and Immunotherapeutic Mechanistic Understanding.
    Diabetes Care. 2025 Apr 24:dc242908. doi: 10.2337/dc24-2908.
    

    >> Share

    
    
39. NADEAU KJ, Mayer-Davis EJ, Gubitosi-Klug R, Zeitler PS, et al
    Youth-Onset Type 2 Diabetes: What We've Learned From Key Youth-Onset Type 2 Diabetes Studies, What We Still Don't Know, and Why It Is Important.
    Diabetes Care. 2025 Apr 24:dc250001. doi: 10.2337/dc25-0001.
    

    >> Share

    
    
40. CRANDALL JP, Dabelea D, Knowler WC, Nathan DM, et al
    The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact.
    Diabetes Care. 2025 Apr 24:dc250014. doi: 10.2337/dc25-0014.
    

    >> Share

    
    
41. CEFALU WT, Cerio RJ, Silva CM, Wallace JA, et al
    NIDDK: Celebrating 75 Years of Advancing Diabetes Research.
    Diabetes Care. 2025 Apr 24:dci250044. doi: 10.2337/dci25-0044.
    

    >> Share

    
    
42. REWERS M, Agardh D, Johnson SB, Bonifacio E, et al
    Unfolding the Mystery of Autoimmunity: The Environmental Determinants of Diabetes in the Young (TEDDY) Study.
    Diabetes Care. 2025 Apr 24:dc242886. doi: 10.2337/dc24-2886.
    

    >> Share

    
    
43. BRAFFETT BH, Bebu I, Lorenzi GM, Martin CL, et al
    The NIDDK Takes on the Complications of Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Diabetes Care. 2025 Apr 24:dc242885. doi: 10.2337/dc24-2885.
    

    >> Share

    
    

    
    Diabetes Obes Metab

44. LI MN, Jin FX, Zhao JJ, Wang Y, et al
    Recurrent hypoglycaemia leads to impairment in glucagon-mediated hepatic glycogenolysis in type 1 diabetic mice.
    Diabetes Obes Metab. 2025 Apr 20. doi: 10.1111/dom.16409.
    

    >> Share

    
    
45. YANO Y, Okami S, Kanegae H, Oberprieler NG, et al
    Transitional changes in medication-initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes-A hospital-based cohort study in Japan.
    Diabetes Obes Metab. 2025 Apr 21. doi: 10.1111/dom.16394.
    

    >> Share

    
    
46. GUO Z, Wallace AS, Rooney MR, Wang D, et al
    Ultra-processed food consumption among adults with prediabetes and diabetes, 2001-2018.
    Diabetes Obes Metab. 2025 Apr 21. doi: 10.1111/dom.16411.
    

    >> Share

    
    
47. HAMAMOTO Y, Usui R
    Imeglimin and DPP-4 inhibitors: A promising therapeutic strategy for type 2 diabetes individuals with reduced insulin secretion.
    Diabetes Obes Metab. 2025 Apr 21. doi: 10.1111/dom.16397.
    

    >> Share

    
    
48. DE RUITER SC, Tschiderer L, Grobbee DE, Ruigrok YM, et al
    Diabetes, glycaemic traits and cardiovascular disease in females and males: Observational and Mendelian randomisation analyses in the UK Biobank.
    Diabetes Obes Metab. 2025 Apr 21. doi: 10.1111/dom.16406.
    

    >> Share

    
    
49. 
    Correction to "A micro-randomized pilot study to examine the impact of just-in-time nudging on after-dinner snacking in adults with type 2 diabetes: A study protocol".
    Diabetes Obes Metab. 2025 Apr 21. doi: 10.1111/dom.16412.
    

    >> Share

    
    
50. LEE CMY, Gibson AA, Nassar N, Colagiuri S, et al
    Long-term adherence to glucose-lowering medications in adults with diabetes: A data linkage study.
    Diabetes Obes Metab. 2025 Apr 23. doi: 10.1111/dom.16408.
    

    >> Share

    
    
51. ZHANG Z, Huang Z, Xi Y, Han S, et al
    Association between adherence to the EAT-Lancet diet and risk of microvascular complications in type 2 diabetes: A cohort study.
    Diabetes Obes Metab. 2025 Apr 23. doi: 10.1111/dom.16414.
    

    >> Share

    
    
52. CARUSO P, Maiorino MI, Longo M, Maio A, et al
    Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18-month follow-up of a randomized clinical trial.
    Diabetes Obes Metab. 2025 Apr 25. doi: 10.1111/dom.16419.
    

    >> Share

    
    

    
    Diabetologia

53. CIANGURA C, Seco A, Saint-Martin C, Ancel PY, et al
    Pregnancy and neonatal outcomes in women with GCK-MODY: an observational study based on standardised insulin modalities.
    Diabetologia. 2025;68:981-992.
    

    >> Share

    
    
54. BRUCE DG, Davis WA, Chubb SAP, Davis TME, et al
    The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase II.
    Diabetologia. 2025 Apr 21. doi: 10.1007/s00125-025-06430.
    

    >> Share

    
    
55. ZHOU J, Mychaleckyj JC, Onengut-Gumuscu S, Orchard TJ, et al
    DNA methylation and 28 year incidence of two neuropathy phenotypes in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort study.
    Diabetologia. 2025 Apr 23. doi: 10.1007/s00125-025-06427.
    

    >> Share

    
    
56. EEG-OLOFSSON K, Nathanson D, Spelman T, Kyhlstedt M, et al
    Severe hypoglycaemia is associated with increased risk of adverse cardiovascular complications in adults with type 1 diabetes: risk mitigation using intermittently scanned continuous glucose monitoring.
    Diabetologia. 2025 Apr 24. doi: 10.1007/s00125-025-06438.
    

    >> Share

    
    

    
    Invest Ophthalmol Vis Sci

57. XIAO X, Zhao J, Lin S, Yang Y, et al
    Relationships Between Retinal Vascular Characteristics and Systemic Indicators in Patients With Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2025;66:72.
    

    >> Share

    
    
58. HA SK, Ding X, Romano F, Overbey KM, et al
    Structure-Function Associations Between Quantitative Contrast Sensitivity Function And Peripapillary Optical Coherence Tomography Angiography in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:69.
    

    >> Share

    
    
59. PAN SY, Weng CH, Tsai SF, Lin HJ, et al
    Use of SGLT2 Inhibitors Versus DPP-4 Inhibitors and Age-Related Macular Degeneration in Patients WithType 2 Diabetes: A Multinational Cohort Study.
    Invest Ophthalmol Vis Sci. 2025;66:58.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

60. HSU JC, Huang KC, Lin TT, Lee JK, et al
    Epicardial Adipose Tissue Is Associated With Geometry Alteration and Diastolic Dysfunction in Prediabetic Cardiomyopathy.
    J Clin Endocrinol Metab. 2025;110:1478-1487.
    

    >> Share

    
    
61. KANG F, Zhang Z, Fu H, Sun J, et al
    beta-Cell Dedifferentiation in HOMA-betalow and HOMA-betahigh Subjects.
    J Clin Endocrinol Metab. 2025;110:e1430-e1438.
    

    >> Share

    
    
62. BRANDT IAG, Vestergaard P, Harslof T, Juhl CB, et al
    Association between Muscle status and Bone Size, Density, and Strength in Type 1 Diabetes: A Cross-Sectional Study.
    J Clin Endocrinol Metab. 2025 Apr 23:dgaf245. doi: 10.1210.
    

    >> Share

    
    
63. JAEGER B, Casanova R, Demesie Y, Stafford J, et al
    Development and validation of a diabetes risk prediction model with individualized preventive intervention effects.
    J Clin Endocrinol Metab. 2025 Apr 23:dgaf250. doi: 10.1210.
    

    >> Share

    
    

    
    J Diabetes Complications

64. VOZIKI D, Dimakopoulos G, Stergiou I, Zografou I, et al
    The effects of SGLT2 inhibitors and GLP-1 receptor agonists on the triglyceride to HDL cholesterol ratio and the triglyceride-glucose index in patients with type 2 diabetes.
    J Diabetes Complications. 2025;39:109044.
    

    >> Share

    
    

    
    J Hypertens

65. LIN RT, Gao JW, Yang YC, Chen XW, et al
    Optimizing benefits of intensive SBP control in type 2 diabetes: the crucial role of angiotensin-converting enzyme inhibitors/angiotensin-II type 2 receptor blockers.
    J Hypertens. 2025 Apr 22. doi: 10.1097/HJH.0000000000004037.
    

    >> Share

    
    

    
    Kidney Int

66. DE BOER IH, Caramori ML, Chan JCN, Heerspink HJL, et al
    GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease-a KDIGO commentary.
    Kidney Int. 2025;107:767-771.
    

    >> Share

    
    

    
    Ophthalmology

67. ZAIDI Z, Alshaikhsalama A, Alsoudi A, Rahimy E, et al
    Re: Vasu et al.: Risk of glaucoma in non-diabetic patients using a glucagon like peptide-1 receptor agonist (Ophthalmology. 2025 Feb 18:S0161-6420(25)00132-0).
    Ophthalmology. 2025 Apr 22:S0161-6420(25)00184.
    

    >> Share

    
    

    
    PLoS One

68. AVORGBEDOR F, McCoy TP, Mittal A, Hubbard L, et al
    Life stressors, hypertensive disorders of pregnancy, and gestational diabetes by race/ethnicity.
    PLoS One. 2025;20:e0321615.
    

    >> Share

    
    
69. PYO J, Jeong H, Mahmudah NA, Park YK, et al
    Comparative analysis of oral health behaviour and utilisation of oral health care services in the general population and among patients with non-communicable diseases in Korea: a repeated cross-sectional survey conducted from 2008 to 2022.
    PLoS One. 2025;20:e0321816.
    

    >> Share

    
    
70. ABDLSHIKURE SA, Mamo AG, Fikadu B, Seid A, et al
    Prevalence and determinants of erectile dysfunction among type 2 diabetes mellitus patients at selected government hospitals in gurage zone: A cross-sectional study.
    PLoS One. 2025;20:e0318908.
    

    >> Share

    
    
71. WANYERA P, Nakabembe E, Kagawa MN
    Fetal macrosomia and its associated factors among pregnant women delivered at national referral hospital in Uganda, a case-control study.
    PLoS One. 2025;20:e0294543.
    

    >> Share

    
    
72. ROBLES-CABRERA A, Lerma C, Ruiz-Velasco Acosta S, Perez-Diaz I, et al
    Sex hormones correlate with heart rate variability in healthy women and this correlation is conserved in women with well-controlled type 2 diabetes mellitus.
    PLoS One. 2025;20:e0320982.
    

    >> Share

    
    
73. SHABNAM S, Zaccardi F, Yates T, Islam N, et al
    COVID-19 pandemic and risk factor measurement in individuals with cardio-renal-metabolic diseases: A retrospective study in the United Kingdom.
    PLoS One. 2025;20:e0319438.
    

    >> Share

    
    
74. CHOI B, Kim K, Park HJ, Song YK, et al
    Onsite clinic utilization and adherence in semiconductor employees at chronic disease risk.
    PLoS One. 2025;20:e0321252.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

75. NISHIO M, Yamaguchi K, Otani J, Yuguchi K, et al
    MOB1 deletion in murine mature adipocytes ameliorates obesity and diabetes.
    Proc Natl Acad Sci U S A. 2025;122:e2424741122.
    

    >> Share

    
    

    
    Retina

76. MONTESEL A, Sen S, Preston E, Patel PJ, et al
    Intraocular Inflammation (IOI) Associated with Faricimab Therapy: One-year Real World Outcomes.
    Retina. 2025 Jan 2. doi: 10.1097/IAE.0000000000004394.
    

    >> Share

    
    
77. WANG X, Wang X, Zhang W, Zhang Y, et al
    Hyperfluorescent spots in late frames of indocyanine green angiography: a new target for diabetic macular edema.
    Retina. 2025 Apr 16. doi: 10.1097/IAE.0000000000004490.
    

    >> Share

    
    

    
    WMJ

78. PARIKH SB, LaMantia JN, Brennan MB, Tischendorf JS, et al
    Next Steps: Teaching Future Generations an Interprofessional Approach to Diabetic Foot Ulcer Care.
    WMJ. 2025;124:55-58.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share